# FDA Inspection 1079760 - Eversight - February 19, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/eversight/285db24c-5d76-400c-88fa-2bf57d1df4ab
Source feed: FDA_Inspections

> FDA Inspection 1079760 for Eversight on February 19, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079760
- Company Name: Eversight
- Inspection Date: 2019-02-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1178408 - 2022-08-18](https://www.globalkeysolutions.net/records/fda_inspections/eversight/5ef4ff5a-d236-47ef-b35a-4df92066b204)
- [FDA Inspection 1178408 - 2022-08-18](https://www.globalkeysolutions.net/records/fda_inspections/eversight/fc7c58fe-aa8d-404f-b6ba-a6529d077969)
- [FDA Inspection 1079760 - 2019-02-19](https://www.globalkeysolutions.net/records/fda_inspections/eversight/f5b96dfd-2077-4230-ba3f-e2e08e875fe4)
- [FDA Inspection 986660 - 2016-09-22](https://www.globalkeysolutions.net/records/fda_inspections/eversight/3efd8637-3793-41c8-a41c-41b0b6084015)
- [FDA Inspection 986660 - 2016-09-22](https://www.globalkeysolutions.net/records/fda_inspections/eversight/2570cf1a-da1a-4000-8ef4-fbf76869fd8d)

Company: https://www.globalkeysolutions.net/companies/eversight/3e2c7eb6-1612-4466-aafd-abe8c42da52c

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
